Clinical Trials Logo

Clinical Trial Details — Status: Unknown status

Administrative data

NCT number NCT01460017
Other study ID # E-11-487
Secondary ID
Status Unknown status
Phase Phase 1
First received October 25, 2011
Last updated October 25, 2011
Start date November 2011
Est. completion date December 2013

Study information

Verified date October 2011
Source King Saud University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators hypothesize that deep sclerectomy in congenital glaucoma is a safer procedure and may yield better results than trabeculotomy trabeculectomy approach.


Description:

Non penetrating glaucoma surgery depends on filtration through trabeculo-descmeto window as well as supra-choroidal space less to sub-conjunctival rout. the nature of the operation keeps the globe intact without penetration that leads to less complications compared to penetrating trabeculectomy combined with trabeculotomy.


Recruitment information / eligibility

Status Unknown status
Enrollment 40
Est. completion date December 2013
Est. primary completion date November 2013
Accepts healthy volunteers No
Gender All
Age group N/A to 12 Years
Eligibility Inclusion Criteria:

- Any case diagnosed as congenital glaucoma with enlarged corneal diameter more than 11 mm and intra-ocular pressure above 21 mmHg, including corneal edema or Habb's Stria with or without optic disc cupping.

- Any case diagnosed as primary or secondary congenital glaucoma to ocular or systemic abnormalities.

- Within the age of (0 - 12).

Exclusion Criteria:

- Cases of congenital glaucoma with previous intervention.

- Age above 12 Yrs.

- Cases with secondary glaucoma caused by surgical intervention, ocular co-morbidity, medications or trauma

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Deep Sclerectomy
Non penetrating glaucoma surgery is a new procedure in adults that has less post operative complications with good results, it is to be applied in children.
Combined Trab
Combined trabeculectomy and trabeculotomy is a standard surgery for congenital glaucoma, however, it has its known complications.

Locations

Country Name City State
Saudi Arabia King Abdul Aziz University Hospital Riyadh

Sponsors (1)

Lead Sponsor Collaborator
King Saud University

Country where clinical trial is conducted

Saudi Arabia, 

Outcome

Type Measure Description Time frame Safety issue
Primary reduction in IOP decrease in the intraocular pressure to the normal limit (<22 - >6) mmHg 6 month
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02121171 - Combined Trab+Trab Versus Combined Trab+Trab With Subconjunctival Implantation of Ologen for Primary Congenital Glaucoma Phase 1
Not yet recruiting NCT05115708 - Kahook Dual Blade Ab-interno Trabeculotomy Versus ab Externo Viscotrabeculotomy in Primary Congenital Glaucoma N/A
Recruiting NCT01136460 - Genetic Testing in Primary Congenital Glaucoma Patients N/A
Completed NCT02945176 - Safety and Performance Study of the ARGOS-IO System in Patients Undergoing Boston Keratoprosthesis Implantation N/A
Completed NCT05943184 - Cognitive Behavioral Nursing Model N/A
Active, not recruiting NCT06189326 - Non-penetrating Deep Sclerectomy Versus Trabeculotomy- Trabeculectomy Operation in Treatment of Primary Congenital Glaucoma N/A
Active, not recruiting NCT03077789 - Prospective Study of the Diagnostic and Therapeutic Management of Congenital Glaucoma in France N/A